M

MiMedx Group
D

MDXG

9.15000
USD
-0.04
(-0.44%)
Market Open
Volume
24,995
EPS
0
Div Yield
-
P/E
16
Market Cap
1,344,557,849
OverviewSignalsIdeasNews
Related Instruments
    A
    A
    -3.140
    (-2.41%)
    127.100 USD
    A
    ALGN
    2.230
    (1.01%)
    223.930 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    I
    ILMN
    -7.180
    (-5.05%)
    135.110 USD
    I
    IRWD
    0.10500
    (2.56%)
    4.20500 USD
    M
    MTD
    -57.09
    (-4.61%)
    1,180.92 USD
    O
    OSIS
    -1.250
    (-0.82%)
    150.810 USD
    X
    XRAY
    0.385
    (2.15%)
    18.270 USD
    Z
    ZBH
    3.638
    (3.34%)
    112.490 USD
    More
News

Title: MiMedx Group

Sector: Healthcare
Industry: Biotechnology
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.